| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Actin-binding_Xin_repeat | 3.76e-05 | 2 | 115 | 2 | IPR012510 | |
| Domain | XIRP1/XIRP2 | 3.76e-05 | 2 | 115 | 2 | IPR030072 | |
| Domain | XIN | 3.76e-05 | 2 | 115 | 2 | PS51389 | |
| Domain | Xin | 3.76e-05 | 2 | 115 | 2 | PF08043 | |
| Pubmed | KIF21B AGAP5 INO80 ADGRV1 INPP5F CLOCK KMT2C NUP155 NAV2 RPRD2 AGAP9 KAT6B DOCK6 MED13 | 2.93e-09 | 529 | 116 | 14 | 14621295 | |
| Pubmed | 7.08e-08 | 225 | 116 | 9 | 12168954 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 3.60e-07 | 5 | 116 | 3 | 34847625 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | REPS1 NRF1 NSD1 SLCO4A1 INO80 REV3L ZNF236 HIVEP3 KMT2C FAT1 TLN1 NAV2 UBE3C DOCK6 MED13 AHNAK2 | 8.57e-07 | 1105 | 116 | 16 | 35748872 |
| Pubmed | PRPF31 TENT4B REPS1 NSD1 ZMYM2 INO80 PIAS1 KMT2C PHC3 TLN1 LTN1 CRYBG1 ATF1 HCFC2 HOMER3 SDC4 MED13 RAD23B | 2.37e-06 | 1497 | 116 | 18 | 31527615 | |
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 2.99e-06 | 9 | 116 | 3 | 25065622 | |
| Pubmed | ZBTB33 ZMYM2 ZNF236 CLOCK PIAS1 ZBTB24 HIVEP3 ARNT2 ELF1 ATF1 USF1 KAT6B NFAT5 | 3.19e-06 | 808 | 116 | 13 | 20412781 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B CELF5 PRPF31 OPA1 RYR3 KMT2C TAOK3 XIRP2 NAV2 ANKRD28 | 6.85e-06 | 497 | 116 | 10 | 36774506 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 NRF1 APBB2 HIPK2 ADGRV1 ZNF236 ITPK1 HIVEP3 KMT2C USF3 ANTXR1 RPRD2 DCLK2 UBE3C KAT6B DOCK6 NFAT5 | 9.21e-06 | 1489 | 116 | 17 | 28611215 |
| Pubmed | Emergence of Xin demarcates a key innovation in heart evolution. | 1.10e-05 | 2 | 116 | 2 | 18682726 | |
| Pubmed | Instillation of hyaluronan reverses acid instillation injury to the mammalian blood gas barrier. | 1.10e-05 | 2 | 116 | 2 | 29368549 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 21591583 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19131637 | ||
| Pubmed | Sotos syndrome, infantile hypercalcemia, and nephrocalcinosis: a contiguous gene syndrome. | 1.10e-05 | 2 | 116 | 2 | 21597970 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22584245 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 23261932 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26936456 | ||
| Pubmed | Structure, Expression, and Function of a Novel Intercalated Disc Protein, Xin. | 1.10e-05 | 2 | 116 | 2 | 16708114 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZBTB33 FOXN4 ZNF236 CLOCK ZBTB24 HIVEP3 BNC1 USF3 ARNT2 ELF1 ATF1 USF1 NFAT5 | 1.11e-05 | 908 | 116 | 13 | 19274049 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 1.32e-05 | 536 | 116 | 10 | 15840001 | |
| Pubmed | 1.36e-05 | 538 | 116 | 10 | 10512203 | ||
| Pubmed | Genome-wide association study identifies multiple loci influencing human serum metabolite levels. | 1.72e-05 | 46 | 116 | 4 | 22286219 | |
| Pubmed | 1.96e-05 | 16 | 116 | 3 | 30291028 | ||
| Pubmed | ZBTB33 DNAH10 HIPK2 ZMYM2 INO80 PIAS1 KMT2C PHC3 FAT1 PABPC3 RLIM ANKRD28 ELF1 RPRD2 ATF1 HCFC2 | 2.20e-05 | 1429 | 116 | 16 | 35140242 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19776007 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 33316546 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 15696473 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 9038233 | ||
| Pubmed | Genetic analysis of the role of Eph receptors in the development of the mammalian nervous system. | 3.30e-05 | 3 | 116 | 2 | 9321682 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28704475 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 1899288 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 3.30e-05 | 3 | 116 | 2 | 7890611 | |
| Pubmed | Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms. | 3.30e-05 | 3 | 116 | 2 | 15023809 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 3.30e-05 | 3 | 116 | 2 | 22341088 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 32380082 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23667648 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19341173 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28877989 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19800850 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 38987795 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 37105392 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 29196099 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 36479526 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 25110219 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 3.30e-05 | 3 | 116 | 2 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 3.30e-05 | 3 | 116 | 2 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 3.30e-05 | 3 | 116 | 2 | 31969388 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 3.30e-05 | 3 | 116 | 2 | 35241678 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 15454575 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22627368 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19099922 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 33153471 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22052881 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 3.30e-05 | 3 | 116 | 2 | 23408620 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23181436 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 3.30e-05 | 3 | 116 | 2 | 29458010 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 26582205 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 9153289 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18974023 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 10915768 | ||
| Pubmed | ABC transporters as differentiation markers in glioblastoma cells. | 3.30e-05 | 3 | 116 | 2 | 25028266 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 3.30e-05 | 3 | 116 | 2 | 29651447 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 21146220 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 25449226 | ||
| Pubmed | Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage. | 3.30e-05 | 3 | 116 | 2 | 27206985 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 3.30e-05 | 3 | 116 | 2 | 28990062 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18579572 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 20064972 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 16990264 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23115302 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18005988 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23585851 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 3.30e-05 | 3 | 116 | 2 | 29433546 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 16497665 | ||
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 3.30e-05 | 3 | 116 | 2 | 25898318 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 31937306 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 21426359 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18282810 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 24083426 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 3.30e-05 | 3 | 116 | 2 | 25931247 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17560833 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.84e-05 | 608 | 116 | 10 | 36089195 | |
| Pubmed | 4.05e-05 | 57 | 116 | 4 | 18022353 | ||
| Pubmed | 4.05e-05 | 187 | 116 | 6 | 26460568 | ||
| Pubmed | PRPF31 ABCC4 NSD1 HIPK2 INPP5F OPA1 BNC1 FAT1 TMEM106C LTN1 ANKRD28 HOMER3 MED13 CNN3 | 5.50e-05 | 1215 | 116 | 14 | 15146197 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 38686388 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 22677125 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 19234217 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 35715604 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 19017954 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 24376512 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 6.59e-05 | 4 | 116 | 2 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 6.59e-05 | 4 | 116 | 2 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 6.59e-05 | 4 | 116 | 2 | 33727589 | |
| GeneFamily | Non-clustered protocadherins | 1.40e-03 | 12 | 85 | 2 | 21 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.92e-03 | 14 | 85 | 2 | 1095 | |
| GeneFamily | Galectins | 2.20e-03 | 15 | 85 | 2 | 629 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.84e-03 | 17 | 85 | 2 | 1291 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.84e-03 | 17 | 85 | 2 | 486 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | TAPBPL RBL2 APBB2 NSD1 HIPK2 ZMYM2 TNFRSF11A PIAS1 PHC3 SMPDL3A ATXN3 CD44 PRICKLE2 ANKRD28 RASSF4 | 2.85e-06 | 807 | 116 | 15 | M16651 |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP | 2.91e-06 | 198 | 116 | 8 | M3596 | |
| Coexpression | GSE30083_SP3_VS_SP4_THYMOCYTE_DN | 3.14e-06 | 200 | 116 | 8 | M5037 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 3.14e-06 | 200 | 116 | 8 | M9463 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 3.14e-06 | 200 | 116 | 8 | M8648 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | APBB2 ZMYM2 INPP5F REV3L CLOCK OPA1 FAT1 TAOK3 ARNT2 LTN1 ANKRD28 MTCL1 KAT6B MED13 RAD23B | 5.81e-06 | 856 | 116 | 15 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KIF21B CELF5 MUC19 REV3L GRM5 PCDH17 HIVEP3 TAOK3 PCDH19 GLRA2 ARNT2 PRICKLE2 DCLK2 HCFC2 KIF13A AHNAK2 PDZRN4 | 7.50e-06 | 1106 | 116 | 17 | M39071 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B RBL2 NSD1 EVI2B REV3L ITGAE HIVEP3 KMT2C PHC3 TAOK3 TLN1 CD44 CRYBG1 ANKRD28 ELF1 TMEM123 KAT6B NFAT5 MED13 | 2.94e-05 | 1492 | 116 | 19 | M40023 |
| Coexpression | GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP | 3.03e-05 | 199 | 116 | 7 | M8435 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 4.36e-05 | 466 | 116 | 10 | M13522 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | HIVEP3 TMEM106C TLN1 ARNT2 CD44 NAV2 CNTN3 MTCL1 RASSF4 SDC4 CNN3 | 4.46e-05 | 567 | 116 | 11 | M2129 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_SPP1_POS_MACROPHAGE_CELL | 6.10e-05 | 48 | 116 | 4 | M45740 | |
| Coexpression | BROWNE_HCMV_INFECTION_6HR_DN | 9.21e-05 | 164 | 116 | 6 | M10311 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | CELF5 ABCC4 ABCA1 ZBTB33 NSD1 REV3L PIAS1 PCDH17 RYR3 GLRA2 ARNT2 ATXN3 CNTN3 RPRD2 NFAT5 MED13 DKK3 | 1.52e-06 | 818 | 113 | 17 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | ABCC4 ABCA1 UGT1A10 INO80 RYR3 ACE2 CD44 CRYBG1 ELF1 RPRD2 TMEM123 NFAT5 SDC4 MED13 DKK3 AHNAK2 | 3.41e-06 | 774 | 113 | 16 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | ABCA1 ZBTB33 NSD1 REV3L PCDH17 ARNT2 ATXN3 RPRD2 NFAT5 MED13 | 1.08e-05 | 330 | 113 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | ABCC4 ABCA1 HIPK2 REV3L PCDH17 RYR3 ARNT2 MTCL1 NFAT5 MED13 DKK3 | 1.13e-05 | 407 | 113 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | ABCC4 UGT1A10 HIPK2 INO80 REV3L RYR3 CRYBG1 ELF1 RPRD2 TMEM123 NFAT5 SDC4 MED13 DKK3 AHNAK2 | 1.48e-05 | 772 | 113 | 15 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 1.51e-05 | 149 | 113 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | ABCC4 ABCA1 ZBTB33 NSD1 INO80 REV3L PCDH17 RYR3 BNC1 PCDH19 ARNT2 CNTN3 MTCL1 MED13 DKK3 | 2.44e-05 | 806 | 113 | 15 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | A2M REPS1 HIPK2 TTC27 PCDH17 ACE2 NUP155 PCDH19 ARNT2 PRICKLE2 CNTN3 ANKRD28 DOCK6 NFAT5 DKK3 | 4.80e-05 | 855 | 113 | 15 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | MPO ABCC4 ABCA1 APBB2 HIPK2 EVI2B INO80 OPA1 PCDH17 HIVEP3 RASSF4 DOCK6 NFAT5 MED13 | 5.49e-05 | 764 | 113 | 14 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_500 | ABCA1 APBB2 SLCO4A1 PCDH17 JAM2 SMPDL3A CRYBG1 ELF1 DOCK6 NFAT5 | 7.87e-05 | 417 | 113 | 10 | gudmap_kidney_adult_RenMedVasc_Tie2_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 8.14e-05 | 194 | 113 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.29e-04 | 209 | 113 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.29e-04 | 209 | 113 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.32e-04 | 146 | 113 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.47e-04 | 149 | 113 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | ABCA1 APBB2 SLCO4A1 CLOCK PCDH17 JAM2 PHC3 SMPDL3A LTN1 CRYBG1 ANKRD28 ELF1 DOCK6 NFAT5 | 1.69e-04 | 850 | 113 | 14 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | EPHB3 CELF5 ABCA1 RBL2 ADGRV1 JAM2 KMT2C FAT1 TAOK3 PCDH19 ARNT2 CNTN3 HCFC2 | 1.72e-04 | 747 | 113 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_500 | 1.82e-04 | 21 | 113 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.95e-04 | 379 | 113 | 9 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | REPS1 HIPK2 TTC27 INO80 ADGRV1 REV3L NUP155 CNTN3 ANKRD28 RPRD2 NFAT5 MED13 RAD23B | 2.58e-04 | 779 | 113 | 13 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.67e-04 | 312 | 113 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | EPHB3 CELF5 ABCA1 RBL2 HIPK2 ADGRV1 SHC3 JAM2 FAT1 TAOK3 PCDH19 ARNT2 DCLK2 HCFC2 | 2.80e-04 | 893 | 113 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | EPHB3 CELF5 ABCA1 RBL2 ADGRV1 JAM2 FAT1 TAOK3 PCDH19 ARNT2 HCFC2 TMEM123 | 2.84e-04 | 683 | 113 | 12 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | ABCC4 UGT1A10 NSD1 HIPK2 SLCO4A1 INO80 REV3L ARNT2 CNTN3 NFAT5 MED13 DKK3 PDZRN4 | 3.14e-04 | 795 | 113 | 13 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 3.36e-04 | 408 | 113 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ABCC4 ABCA1 HIPK2 INO80 REV3L PCDH17 RYR3 ARNT2 PRICKLE2 MTCL1 NFAT5 MED13 DKK3 | 3.58e-04 | 806 | 113 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | EPHB3 CELF5 ABCA1 RBL2 HIPK2 ADGRV1 FAT1 TAOK3 PCDH19 ARNT2 HCFC2 | 4.37e-04 | 614 | 113 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_500 | 4.58e-04 | 120 | 113 | 5 | gudmap_kidney_adult_RenMedVasc_Tie2_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | EPHB3 CELF5 ABCA1 RBL2 JAM2 KMT2C FAT1 TAOK3 PCDH19 ARNT2 HCFC2 KAT6B | 4.62e-04 | 721 | 113 | 12 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.65e-04 | 339 | 113 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB3 CELF5 ABCA1 RBL2 JAM2 KMT2C FAT1 TAOK3 PCDH19 ARNT2 HCFC2 TMEM123 | 4.67e-04 | 722 | 113 | 12 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.99e-04 | 261 | 113 | 7 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | EPHB3 CELF5 ABCA1 RBL2 JAM2 KMT2C FAT1 TAOK3 PCDH19 ARNT2 HCFC2 KAT6B | 5.15e-04 | 730 | 113 | 12 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#1_top-relative-expression-ranked_200 | 5.92e-04 | 31 | 113 | 3 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_200_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB3 CELF5 ABCA1 RBL2 ADGRV1 JAM2 KMT2C FAT1 TAOK3 PCDH19 ARNT2 HCFC2 | 6.02e-04 | 743 | 113 | 12 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | EPHB3 CELF5 ABCA1 TAPBPL RBL2 JAM2 KMT2C FAT1 TAOK3 PCDH19 ARNT2 HCFC2 | 6.31e-04 | 747 | 113 | 12 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.48e-04 | 447 | 113 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#2_top-relative-expression-ranked_200 | 6.50e-04 | 32 | 113 | 3 | gudmap_developingKidney_e15.5_Medullary collecting duct_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 7.28e-04 | 201 | 113 | 6 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB3 CELF5 ABCA1 TAPBPL RBL2 JAM2 FAT1 TAOK3 PCDH19 ARNT2 HCFC2 | 7.74e-04 | 658 | 113 | 11 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | EPHB3 CELF5 ABCA1 RBL2 ADGRV1 SHC3 JAM2 TAOK3 PCDH19 ARNT2 HCFC2 | 7.84e-04 | 659 | 113 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 8.01e-04 | 78 | 113 | 4 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.09e-04 | 369 | 113 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CELF5 ABCA1 HIPK2 REV3L PCDH17 NUP155 CRYBG1 CNTN3 KAT6B NFAT5 MED13 DKK3 | 8.13e-04 | 769 | 113 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF21B ZBTB33 TAPBPL RBL2 SLCO4A1 PIAS1 HIVEP3 NUP155 UBE3C KIF13A | 1.27e-11 | 158 | 116 | 10 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 3.32e-08 | 187 | 116 | 8 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 4.97e-08 | 197 | 116 | 8 | a05237ee6d31d9eab491dd7007859d6285cf1424 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 160 | 116 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 160 | 116 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-07 | 180 | 116 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.67e-07 | 185 | 116 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.32e-07 | 188 | 116 | 7 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 6.78e-07 | 190 | 116 | 7 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-07 | 191 | 116 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.53e-07 | 193 | 116 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-07 | 195 | 116 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-07 | 195 | 116 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.35e-07 | 196 | 116 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.10e-06 | 161 | 116 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 4.10e-06 | 161 | 116 | 6 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.10e-06 | 161 | 116 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 4.10e-06 | 161 | 116 | 6 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-06 | 169 | 116 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-06 | 177 | 116 | 6 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-06 | 178 | 116 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-06 | 181 | 116 | 6 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-06 | 181 | 116 | 6 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-06 | 181 | 116 | 6 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-06 | 184 | 116 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-06 | 184 | 116 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-06 | 184 | 116 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 9.09e-06 | 185 | 116 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 9.09e-06 | 185 | 116 | 6 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.37e-06 | 186 | 116 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.37e-06 | 186 | 116 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 9.66e-06 | 187 | 116 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.96e-06 | 188 | 116 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.03e-05 | 189 | 116 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 189 | 116 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 189 | 116 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 190 | 116 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 190 | 116 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-05 | 190 | 116 | 6 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 191 | 116 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 191 | 116 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.09e-05 | 191 | 116 | 6 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 191 | 116 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 191 | 116 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 192 | 116 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-05 | 192 | 116 | 6 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 192 | 116 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-05 | 192 | 116 | 6 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.12e-05 | 192 | 116 | 6 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 192 | 116 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 194 | 116 | 6 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 194 | 116 | 6 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 195 | 116 | 6 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 196 | 116 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.26e-05 | 196 | 116 | 6 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 196 | 116 | 6 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 196 | 116 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.26e-05 | 196 | 116 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 196 | 116 | 6 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 196 | 116 | 6 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-05 | 197 | 116 | 6 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.30e-05 | 197 | 116 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.30e-05 | 197 | 116 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-05 | 197 | 116 | 6 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.30e-05 | 197 | 116 | 6 | c838d0f64e3b43a616a9e381b8139bfe9aa32da7 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.34e-05 | 198 | 116 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 198 | 116 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon|organoid_Velasco_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-05 | 198 | 116 | 6 | a6f65bb0845d8f64f5c7edb00cee3ca5adb1a373 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-05 | 198 | 116 | 6 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.34e-05 | 198 | 116 | 6 | 56b746e5791b47fe33a7872f0942ae0747b13d4a | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 198 | 116 | 6 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | (6)_Endothelial-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.34e-05 | 198 | 116 | 6 | a5e1b321376caf262ea48904d31afd1b8e9d3be2 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-05 | 198 | 116 | 6 | 00fdee373eaa43c9ce897f2ba2ecbe94cedea93a | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-05 | 199 | 116 | 6 | bff61a784ef8bc040f5c7baabccaf7a7cddd5a31 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.38e-05 | 199 | 116 | 6 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.38e-05 | 199 | 116 | 6 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-05 | 199 | 116 | 6 | 3cb1d9d9de64ed0a56c4f8d5e2fa02a13a73d8ac | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.38e-05 | 199 | 116 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 2d962c9d63e9e5f1a06870e383609672e7b1738c | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-05 | 200 | 116 | 6 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 5ab588808c1fc384019413401ab4bf9bc06bf529 | |
| ToppCell | Biopsy_Other_PF-Endothelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.41e-05 | 200 | 116 | 6 | f9916134486fb1dac55f5e7e8deb35e7a3b85770 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 2989325b0e78ab42f362cfb59e34a4fce7f8e869 | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-05 | 200 | 116 | 6 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-05 | 200 | 116 | 6 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 200 | 116 | 6 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-05 | 200 | 116 | 6 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 6a3ccd0ea742fa76282c2b0fbc59942b4ef47bb8 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.74e-05 | 151 | 116 | 5 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.70e-05 | 157 | 116 | 5 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 6.23e-05 | 160 | 116 | 5 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 6.81e-05 | 163 | 116 | 5 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 164 | 116 | 5 | d2b5f51af7fcffddebe997ee302bacbd85d76852 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-CMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.85e-05 | 168 | 116 | 5 | e223bd7ae2a28c007e8b365f30d50d3bee83ba38 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.85e-05 | 168 | 116 | 5 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.85e-05 | 168 | 116 | 5 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| Disease | HDL cholesterol change measurement | 2.04e-06 | 24 | 113 | 4 | EFO_0007805 | |
| Disease | free cholesterol in small HDL measurement | 9.74e-06 | 35 | 113 | 4 | EFO_0022270 | |
| Disease | total lipids in lipoprotein particles measurement | 3.48e-05 | 48 | 113 | 4 | EFO_0022309 | |
| Disease | superoxide dismutase [Mn]; mitochondrial measurement | 8.68e-05 | 4 | 113 | 2 | EFO_0021981 | |
| Disease | cholesterol to total lipids in very large HDL percentage | 2.27e-04 | 31 | 113 | 3 | EFO_0022243 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 2.27e-04 | 31 | 113 | 3 | EFO_0022249 | |
| Disease | eyelid sagging measurement | 2.50e-04 | 32 | 113 | 3 | EFO_0009360 | |
| Disease | lipoprotein measurement, phospholipid measurement | 3.25e-04 | 85 | 113 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | total lipids in small HDL measurement | 3.27e-04 | 35 | 113 | 3 | EFO_0022311 | |
| Disease | cortical thickness | A2M CELF5 GLOD4 ADGRV1 CLOCK PCDH17 BNC1 DOCK7 NAV2 MTCL1 KIF13A PDZRN4 RAD23B | 3.42e-04 | 1113 | 113 | 13 | EFO_0004840 |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0800610 | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0800396 | |
| Disease | level of Phosphatidylcholine (18:1_18:1) in blood serum | 4.01e-04 | 8 | 113 | 2 | OBA_2045099 | |
| Disease | lipid measurement, lipoprotein measurement | 4.04e-04 | 90 | 113 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | phospholipids in small HDL measurement | 4.18e-04 | 38 | 113 | 3 | EFO_0022296 | |
| Disease | apolipoprotein A 1 measurement | XIRP1 ABCA1 REPS1 DNAH10 CETP NSD1 GRM5 DOCK7 ANKRD28 ATF1 DOCK6 | 4.20e-04 | 848 | 113 | 11 | EFO_0004614 |
| Disease | phosphatidylinositol measurement | 4.96e-04 | 95 | 113 | 4 | EFO_0010230 | |
| Disease | plasma renin activity measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0006828 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.51e-04 | 264 | 113 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | Adenoid Cystic Carcinoma | 6.03e-04 | 100 | 113 | 4 | C0010606 | |
| Disease | spleen volume | 6.04e-04 | 43 | 113 | 3 | EFO_0600047 | |
| Disease | cerebral palsy (implicated_via_orthology) | 6.41e-04 | 10 | 113 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 7.24e-04 | 105 | 113 | 4 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | lipoprotein measurement | 7.24e-04 | 105 | 113 | 4 | EFO_0004732 | |
| Disease | glycerophosphorylcholine measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0020018 | |
| Disease | phosphoglycerides measurement | 8.34e-04 | 48 | 113 | 3 | EFO_0022291 | |
| Disease | cholestasis (biomarker_via_orthology) | 8.86e-04 | 49 | 113 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 8.91e-04 | 111 | 113 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | forced expiratory volume | TENT4B INO80 PIAS1 ZBTB24 ITPK1 SLC34A1 ATXN3 RPRD2 MTCL1 NFAT5 | 9.22e-04 | 789 | 113 | 10 | EFO_0004314 |
| Disease | peripheral arterial disease, traffic air pollution measurement | 9.22e-04 | 194 | 113 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | alpha-hydroxybutyric acid measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0010458 | |
| Disease | metabolic syndrome | 1.06e-03 | 200 | 113 | 5 | EFO_0000195 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 1.10e-03 | 13 | 113 | 2 | OBA_2045159 | |
| Disease | Hyperlipoproteinemia Type IIb | 1.10e-03 | 13 | 113 | 2 | C1704417 | |
| Disease | total phospholipids in lipoprotein particles measurement | 1.11e-03 | 53 | 113 | 3 | EFO_0022315 | |
| Disease | triglycerides in HDL measurement | 1.11e-03 | 53 | 113 | 3 | EFO_0022317 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.23e-03 | 121 | 113 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | triglycerides in medium VLDL measurement | 1.24e-03 | 55 | 113 | 3 | EFO_0022155 | |
| Disease | triglycerides in very large HDL measurement | 1.24e-03 | 55 | 113 | 3 | EFO_0022324 | |
| Disease | phospholipids in medium HDL measurement | 1.24e-03 | 55 | 113 | 3 | EFO_0022295 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 1.24e-03 | 55 | 113 | 3 | EFO_0022288 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.28e-03 | 14 | 113 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.28e-03 | 14 | 113 | 2 | OBA_2045100 | |
| Disease | total lipids in medium HDL measurement | 1.45e-03 | 58 | 113 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 1.45e-03 | 58 | 113 | 3 | EFO_0022267 | |
| Disease | docosahexaenoic acid measurement | 1.47e-03 | 127 | 113 | 4 | EFO_0007761 | |
| Disease | esterified cholesterol measurement | 1.51e-03 | 128 | 113 | 4 | EFO_0008589 | |
| Disease | cholesterol in medium HDL measurement | 1.52e-03 | 59 | 113 | 3 | EFO_0021903 | |
| Disease | choline measurement | 1.60e-03 | 130 | 113 | 4 | EFO_0010116 | |
| Disease | polyunsaturated fatty acid measurement | 1.64e-03 | 131 | 113 | 4 | EFO_0010733 | |
| Disease | triglycerides in small VLDL measurement | 1.67e-03 | 61 | 113 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.67e-03 | 61 | 113 | 3 | EFO_0022274 | |
| Disease | free cholesterol in HDL measurement | 1.67e-03 | 61 | 113 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 1.67e-03 | 61 | 113 | 3 | EFO_0022293 | |
| Disease | Hyperlipoproteinemia Type IIa | 1.68e-03 | 16 | 113 | 2 | C0745103 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 1.68e-03 | 16 | 113 | 2 | OBA_2045090 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.69e-03 | 132 | 113 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | Intellectual Disability | 1.70e-03 | 447 | 113 | 7 | C3714756 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.71e-03 | 713 | 113 | 9 | EFO_0005689 | |
| Disease | phospholipids in large VLDL measurement | 1.75e-03 | 62 | 113 | 3 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 1.75e-03 | 62 | 113 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 1.75e-03 | 62 | 113 | 3 | EFO_0022299 | |
| Disease | coronary artery calcification | 1.77e-03 | 450 | 113 | 7 | EFO_0004723 | |
| Disease | total lipids in HDL measurement | 1.84e-03 | 63 | 113 | 3 | EFO_0022307 | |
| Disease | phospholipids:total lipids ratio | 1.85e-03 | 227 | 113 | 5 | EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.90e-03 | 17 | 113 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 1.90e-03 | 17 | 113 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | cholesterol in large VLDL measurement | 2.01e-03 | 65 | 113 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 2.01e-03 | 65 | 113 | 3 | EFO_0022230 | |
| Disease | phospholipid measurement | 2.10e-03 | 140 | 113 | 4 | EFO_0004639 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 2.14e-03 | 18 | 113 | 2 | OBA_2045155 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 2.14e-03 | 18 | 113 | 2 | OBA_2045065 | |
| Disease | Hypercholesterolemia, Familial | 2.14e-03 | 18 | 113 | 2 | C0020445 | |
| Disease | stem Cell Factor measurement | 2.19e-03 | 67 | 113 | 3 | EFO_0008291 | |
| Disease | total lipids in small VLDL | 2.19e-03 | 67 | 113 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 2.19e-03 | 67 | 113 | 3 | EFO_0022175 | |
| Disease | triglycerides to phosphoglycerides ratio | 2.29e-03 | 68 | 113 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 2.29e-03 | 68 | 113 | 3 | EFO_0022265 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.48e-03 | 243 | 113 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | visceral adipose tissue measurement | 2.57e-03 | 481 | 113 | 7 | EFO_0004765 | |
| Disease | Prostatic Neoplasms | 2.59e-03 | 616 | 113 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.59e-03 | 616 | 113 | 8 | C0376358 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 2.64e-03 | 20 | 113 | 2 | OBA_2045071 | |
| Disease | phospholipids in large HDL measurement | 2.80e-03 | 73 | 113 | 3 | EFO_0022190 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.89e-03 | 153 | 113 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.89e-03 | 153 | 113 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | total lipids in large HDL | 2.91e-03 | 74 | 113 | 3 | EFO_0022189 | |
| Disease | COVID-19 (is_implicated_in) | 2.91e-03 | 21 | 113 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | cardiovascular system disease (is_implicated_in) | 2.91e-03 | 21 | 113 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 2.91e-03 | 21 | 113 | 2 | OBA_2045156 | |
| Disease | cholesteryl ester measurement | 3.15e-03 | 257 | 113 | 5 | EFO_0010351 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 3.49e-03 | 23 | 113 | 2 | OBA_2045158 | |
| Disease | free cholesterol in large HDL measurement | 3.50e-03 | 79 | 113 | 3 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 3.63e-03 | 80 | 113 | 3 | EFO_0021900 | |
| Disease | Attention deficit hyperactivity disorder | 3.80e-03 | 24 | 113 | 2 | C1263846 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVQSFLQSMITAVGI | 421 | P11597 | |
| VSSSNGFTSQVAMKQ | 596 | P32519 | |
| KSTNNFMIVSATGQT | 451 | Q5VTM2 | |
| VFMASSGTTDVTNRN | 16 | Q92870 | |
| QVSMNDGLSFISSSV | 296 | Q9H6X2 | |
| MFLTNVNSSSSSTQI | 286 | O95477 | |
| ESTAFQLMNITAGTS | 4891 | Q8WXG9 | |
| TQQASQTSVIFKGTS | 811 | Q01954 | |
| NGQTNTVEMLVSSAS | 866 | O15084 | |
| QHMGNNTATVTTTTT | 616 | O14490 | |
| QFSINTTNVMGTSLT | 406 | P01023 | |
| QSSSSTGQNMSQISR | 551 | Q9HBZ2 | |
| TSALVTGQSYENMVT | 181 | P54727 | |
| NLRSTMAATQSSSGQ | 771 | Q6ZMN7 | |
| CTMQLSTVSGTSQNA | 46 | Q96L73 | |
| MGSRQQFVQSSSTFK | 866 | O14917 | |
| GSVTNVRVNSTMTTL | 186 | Q9H2L5 | |
| NGSRTMGTQTVQTIS | 1631 | Q9Y4B5 | |
| MGTQTVQTISVGLQT | 1636 | Q9Y4B5 | |
| SMGSTQQAQNTTSSL | 791 | Q9ULG1 | |
| SNISGSCSMLQQTSI | 1726 | Q8WYB5 | |
| ISSVQTSTQLFNGMT | 1611 | O94822 | |
| TLVTMATATVTANNG | 726 | Q08999 | |
| VNDVLNTSVTSMGSQ | 931 | Q8TAB3 | |
| SSQAVGKMQSTQTTN | 491 | Q8NDF8 | |
| GKMQSTQTTNTSNST | 496 | Q8NDF8 | |
| IIQGTNMAGLSTNTT | 1736 | Q14517 | |
| IATVLQGQSTAMAAT | 316 | Q13572 | |
| SSSQGSLMEQISSVV | 1051 | P41594 | |
| TSGVTDTQNTVNMAQ | 2361 | Q8NEZ4 | |
| GSINSPSTQTFMQTN | 3491 | Q8NEZ4 | |
| TSTNLTMTFNNQLTT | 576 | Q9H2X6 | |
| TVSSTQTMVTQQTIK | 516 | Q9Y5Z7 | |
| TSQNTSFDGSLIQKM | 361 | Q86T24 | |
| FMGITLASSQAVSNA | 101 | Q9HC38 | |
| TATNTVGFSSQEMRL | 1046 | Q8NDA2 | |
| VIHTVQSASGQMFSQ | 196 | Q6DKI2 | |
| INVITNMTTTIQSLF | 126 | Q92484 | |
| VIHTVQSASGQMFSQ | 196 | Q3B8N2 | |
| SRNISQDMTQTSGTN | 261 | P54252 | |
| NSTTTGVSVIMNTAL | 681 | Q8N568 | |
| NSTVTPNMTFTKTSQ | 61 | Q9NSC5 | |
| NITQVGSVTKTASAM | 271 | P38570 | |
| TSAQSAGVTMTSIQS | 3036 | Q7Z5P9 | |
| NTGITTVSKNNIFMS | 706 | P05164 | |
| NSFTGQMENITTISQ | 291 | Q5KU26 | |
| QSQPTLFTSSMSQVL | 31 | P34910 | |
| QGALSRTTASTQMNV | 206 | O75037 | |
| GEMTIQTTQASEATQ | 366 | Q16656 | |
| VSMYQTVVTSLAQGN | 456 | Q16656 | |
| GIASTVTSQMNSVQL | 496 | P54753 | |
| MSGSFNLSTLITTQE | 156 | P03886 | |
| TMNTKTGTLQFNTVS | 191 | P57087 | |
| TQQVATPGTTMFQTS | 971 | O94916 | |
| VTQQSSMSQTSINLS | 116 | Q8NDX5 | |
| SSTSGSITQQTMLLG | 146 | Q8NDX5 | |
| SMSSSVAVQAITGNF | 1366 | O75694 | |
| MSTQRVANTSTQTVG | 471 | Q9H361 | |
| SNIGTSVTNTIVALM | 191 | Q06495 | |
| MVTNTSNGQPSTLTI | 1306 | O15439 | |
| VSQNTSQISTSTMTV | 121 | Q8N131 | |
| MSSQSFSETRGSIQV | 486 | Q7Z3G6 | |
| AQTMNSGTFNTTVDI | 641 | O60313 | |
| QMSSSSQIGNDSFQL | 401 | P51797 | |
| VTMSLSSLVGTTQNF | 1506 | Q96HP0 | |
| QVTMSLSSLVGTSQN | 1596 | Q96N67 | |
| LSMTTQQSNSQSFST | 501 | P16070 | |
| GSIQTMRAQLTSTQG | 986 | P29322 | |
| LMQQQTTVLSTSGSY | 251 | Q8N6W0 | |
| LNTILNTMSTIYSTG | 116 | Q9BYF1 | |
| MTSNQSSTLYVTDQG | 306 | O75426 | |
| NIFINSFGSVTETTM | 76 | P23416 | |
| TNTTSTQMTNIGVYV | 301 | Q8NA54 | |
| TSTSNQTLCGEQVMT | 296 | A0A0U1RQI7 | |
| ALYGGQMTTSTSNQT | 526 | A0A0U1RQI7 | |
| QMTTSTSNQTLCGEQ | 531 | A0A0U1RQI7 | |
| QTLCGEQMTTSTSNQ | 581 | A0A0U1RQI7 | |
| LYGGQMTTSTSNQTL | 681 | A0A0U1RQI7 | |
| MTTSTSNQTLCGEQV | 826 | A0A0U1RQI7 | |
| NTMTTAFSTSQNGSL | 856 | Q9Y4K1 | |
| TNIVLMVNFSSRTTS | 2476 | Q8IVF4 | |
| SNKVSMSSTVQGSNI | 126 | P31431 | |
| FQSVTNTMESIQGLS | 31 | Q5VT52 | |
| SSMVQVASITQAGLT | 1076 | Q9Y2H2 | |
| NQTGQMVFSETVITS | 121 | Q9UBP4 | |
| LTISNLSVTDSGMFQ | 371 | Q9P232 | |
| TTQVSMFVLLGFSQT | 6 | Q15615 | |
| TQLTASGNQTMVTEF | 26 | Q8NGW6 | |
| NLGGNSQTSMIATIS | 316 | Q9H1H9 | |
| TSSIMSGIIRNSGQN | 6 | Q96NZ1 | |
| AVTSLSSQIQYMNTV | 151 | Q9BVX2 | |
| SSLDMNRTFTVTTGQ | 561 | Q96D71 | |
| FQVMTQTQSLSFLLG | 191 | Q9BX59 | |
| ITGTSVSQNVVIAMS | 141 | Q15544 | |
| QRTGTSVVLTSINNM | 496 | Q9Y6C5 | |
| NFSQLASPTTVTQMS | 1566 | Q8IVL1 | |
| SNLQFAGMSISLTIS | 216 | Q92529 | |
| STGSQSSSVNSMQEV | 356 | Q9H2K8 | |
| SMSTQANTVQSGQLG | 1571 | Q9UHV7 | |
| STGSVFGRSTTLNMQ | 1931 | Q9UHV7 | |
| FGRSTTLNMQTSQLN | 1936 | Q9UHV7 | |
| QQVQQISSSMDISGT | 176 | O75925 | |
| SLFTVSGMQTVDTIN | 276 | P23515 | |
| SGMQTVDTINSLSVV | 281 | P23515 | |
| QGMTVNGFINTVITS | 116 | Q96BD0 | |
| MISSSVNVLGQQTLT | 5576 | Q8IVF2 | |
| KSTNNFMIVSATGQT | 406 | A6NIR3 | |
| LQTLTMTNSGSTQQG | 131 | P18846 | |
| MTNSGSTQQGTTILQ | 136 | P18846 | |
| NSQSVGSSLTQPVMS | 486 | O15516 | |
| SMPQNSTQSAAVTTF | 681 | O15516 | |
| QTTISLQMGTNKGAS | 201 | Q15417 | |
| STISLQMGTNKVASQ | 241 | Q15417 | |
| VSEIVSSQMNSGSSV | 346 | A4UGR9 | |
| QAQSIFSLLMSSSSG | 101 | Q9HAW8 | |
| SQVAQNTQISSGMSS | 1366 | O60673 | |
| FLVSSSNGTVLNTTM | 161 | O43511 | |
| TQMGNTTTVNVIIST | 3756 | Q15413 | |
| TGTINSSMQAVQAAQ | 496 | Q9Y490 | |
| NTGLSETTSVAIQTM | 391 | Q9NVW2 | |
| NATIMVVSVTASTTQ | 161 | Q8WWY3 | |
| GSAMYTTLSQILVTQ | 1331 | Q5T1R4 | |
| LMAVNVTYSSTGQIA | 1816 | Q9P273 | |
| SNSTQTFSVTMSNQQ | 646 | Q68DE3 | |
| FALQPVMSSSGTTNQ | 671 | Q68DE3 | |
| QGISIVTAESSQNMT | 571 | O43167 | |
| STAMATSLTNVGNSF | 21 | Q9UBW7 | |
| TNSSGTQDLTQVMTS | 1466 | Q9UL36 | |
| TQDLTQVMTSQGLVS | 1471 | Q9UL36 | |
| IFLNSMTQNIFNSTT | 46 | Q6P3X3 | |
| QALVFSASGMIATNT | 606 | Q6BDS2 | |
| DQFGNTVLMSSTTVT | 1776 | Q702N8 | |
| FQSIGVTTSSEMQQC | 576 | Q15386 | |
| TGNSNSTFISSGQVM | 526 | Q9Y6Q6 | |
| ATQSMTQAVIQGAFT | 86 | P22415 | |
| VIGFLMNSEQTSFTS | 161 | Q8WTR2 |